Hepatic hydrothorax is a known complication that occurs in 5-10% of patients with liver cirrhosis and is thought to account for approximately 2% of all pleural effusions. While patients with hepatic hydrothorax typically have ascites, this is not always true. In this case report, we present a 66-year-old female, known to have liver cirrhosis, who presented with recurrent left-side unilateral pleural effusion without ascites that required frequent therapeutic tapping for symptomatic relief. Her unique presentation made the diagnosis of our case challenging, requiring extensive investigations and diagnostic and therapeutic interventions that all led to a diagnosis of a unique presentation of refractory left-sided hepatic hydrothorax. For better quality of life, pleurodesis via video-assisted thoracic surgery was performed until she was ready for liver transplantation. Clinicians should remain vigilant about the possibility of hepatic hydrothorax despite the absence of abdominal ascites.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11876712 | PMC |
http://dx.doi.org/10.7759/cureus.78345 | DOI Listing |
Cureus
February 2025
Internal Medicine, Hamad General Hospital, Doha, QAT.
Hepatic hydrothorax is a known complication that occurs in 5-10% of patients with liver cirrhosis and is thought to account for approximately 2% of all pleural effusions. While patients with hepatic hydrothorax typically have ascites, this is not always true. In this case report, we present a 66-year-old female, known to have liver cirrhosis, who presented with recurrent left-side unilateral pleural effusion without ascites that required frequent therapeutic tapping for symptomatic relief.
View Article and Find Full Text PDFDig Dis Sci
March 2025
Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Introduction: Transjugular intrahepatic portosystemic shunt (TIPS) is an effective intervention for managing major complications of cirrhosis including refractory ascites, hydrothorax, and variceal bleed. The impact of advanced age on outcomes of TIPS has not been studied comprehensively. Therefore, we aimed to study optimal advanced age cutoff in context of MELD score for patients undergoing TIPS.
View Article and Find Full Text PDFIntern Med
February 2025
Department of Diagnostic Pathology, Niigata Prefectural Central Hospital, Japan.
We report the case of a 68-year-old man who presented with pleural effusion and dyspnea during treatment for alcoholic liver cirrhosis. The pleural effusion was transudative and it was diagnosed to be hepatic pleural effusion. Thoracic drainage was continued, but the amount of pleural fluid drainage did not decrease.
View Article and Find Full Text PDFWorld J Gastrointest Surg
January 2025
Department of Surgery, Gastroenterology and Digestive Endoscopy Unit, ASST Santi Paolo e Carlo, University of Milan, Milan 20142, Lombardy, Italy.
Trans-jugular intrahepatic portosystemic stent shunting (TIPSS) has been in use for many years with great results and many evolutions. The procedure essentially involves the insertion of a metal covert stent to create an Hepato-Hepatic portosystemic shunt. Over time, TIPSS has become the subject of many studies aimed at examining its clinical utility and evaluating the results of using TIPSS to manage complications related to portal hypertension.
View Article and Find Full Text PDFJ Hepatocell Carcinoma
January 2025
Department of Interventional and Vascular Surgery, Peking University First Hospital, Beijing, People's Republic of China.
Purpose: Portal vein tumor thrombus (PVTT)-related severe symptomatic portal hypertension (SPH) leads to a poor prognosis in patients with advanced hepatocellular carcinoma (HCC). Traditional transjugular intrahepatic portosystemic shunt (TIPS) using covered plus bare stent can effectively relieve SPH, however, the bare segment is susceptible to obstruction due to PVTT invasion. This study aimed to evaluate the safety and efficacy of fully covered stent-TIPS (FCS-TIPS) for treatment of PVTT-related SPH in advanced HCC patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!